210 related articles for article (PubMed ID: 9224632)
1. Analysis of E-box DNA binding during myeloid differentiation reveals complexes that contain Mad but not Max.
Ryan KM; Birnie GD
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):79-85. PubMed ID: 9224632
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
Larsson LG; Bahram F; Burkhardt H; Lüscher B
Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators.
Sommer A; Bousset K; Kremmer E; Austen M; Lüscher B
J Biol Chem; 1998 Mar; 273(12):6632-42. PubMed ID: 9506959
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
[TBL] [Abstract][Full Text] [Related]
5. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
6. The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes.
Hurlin PJ; Ayer DE; Grandori C; Eisenman RN
Cold Spring Harb Symp Quant Biol; 1994; 59():109-16. PubMed ID: 7587059
[TBL] [Abstract][Full Text] [Related]
7. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells.
Xu D; Popov N; Hou M; Wang Q; Björkholm M; Gruber A; Menkel AR; Henriksson M
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3826-31. PubMed ID: 11274400
[TBL] [Abstract][Full Text] [Related]
8. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
Hurlin PJ; Quéva C; Koskinen PJ; Steingrímsson E; Ayer DE; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1995 Nov; 14(22):5646-59. PubMed ID: 8521822
[TBL] [Abstract][Full Text] [Related]
9. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
Ayer DE; Eisenman RN
Genes Dev; 1993 Nov; 7(11):2110-9. PubMed ID: 8224841
[TBL] [Abstract][Full Text] [Related]
10. Co-induction of Mad1 and c-Myc in activated normal B lymphocytes.
Ertesvåg A; Blomhoff HK; Beiske K; Naderi S
Scand J Immunol; 2000 Jun; 51(6):565-70. PubMed ID: 10849366
[TBL] [Abstract][Full Text] [Related]
11. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells.
Smith AG; Popov N; Imreh M; Axelson H; Henriksson M
J Cell Biochem; 2004 Aug; 92(6):1282-95. PubMed ID: 15258910
[TBL] [Abstract][Full Text] [Related]
12. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
13. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
Vervoorts J; Lüscher B
Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451
[TBL] [Abstract][Full Text] [Related]
14. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
James L; Eisenman RN
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
[TBL] [Abstract][Full Text] [Related]
15. Dynamic in vivo interactions among Myc network members.
Yin X; Landay MF; Han W; Levitan ES; Watkins SC; Levenson RM; Farkas DL; Prochownik EV
Oncogene; 2001 Aug; 20(34):4650-64. PubMed ID: 11498788
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
[TBL] [Abstract][Full Text] [Related]
17. Sequential expression of the MAD family of transcriptional repressors during differentiation and development.
Quéva C; Hurlin PJ; Foley KP; Eisenman RN
Oncogene; 1998 Feb; 16(8):967-77. PubMed ID: 9519870
[TBL] [Abstract][Full Text] [Related]
18. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.
Nair SK; Burley SK
Cell; 2003 Jan; 112(2):193-205. PubMed ID: 12553908
[TBL] [Abstract][Full Text] [Related]
19. Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation.
Cultraro CM; Bino T; Segal S
Mol Cell Biol; 1997 May; 17(5):2353-9. PubMed ID: 9111304
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
